Literature DB >> 18307013

No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan.

Toshiaki Saeki1, Muneo Sano, Yoshifumi Komoike, Hiroshi Sonoo, Hideo Honjyo, Kazunori Ochiai, Tadashi Kobayashi, Kenjiro Aogi, Nobuaki Sato, Seiji Sawai, Yasuo Miyoshi, Yoshio Miyoshi, Masahiro Takeuchi, Shigemitsu Takashima.   

Abstract

Hormone replacement therapy (HRT) has been considered one of the main risk factors for breast cancer. Studies demonstrating the relationship between HRT and breast cancer incidence were conducted in Western countries and the target populations were mainly Caucasians. Since the Women's Health Initiatives demonstrated that HRT increased the risk of breast cancer with statistical significance, the number of HRT users in the United States has dramatically decreased. A recent case-control study has investigated the relationship between HRT and breast cancer in Japan, and here we review the results of this study to compare any discrepancy in breast cancer risk between Japanese and Western populations. For this case-control study, at seven institutions, women between the ages of 45 through 69 years, with histologically confirmed breast cancer, were selected as the case group. An age-adjusted control group was selected, using hospital-based data, including records of those screened for lung, gastrointestinal, and gynecological cancer. Questionnaires were administered, and items questioned included various factors related to the incidence of breast cancer: age at diagnosis, body mass index (BMI), smoking habit, age at menopause, birth history, number of births, number of children, history of breast feeding, familial background, and menopausal status. In total, 6183 samples (98.4% of the estimated samples) were put into the database. Data from 276 samples were excluded due to ineligibility. Finally, 5861 samples (3434 cases and 2427 controls) were analyzed. In 3316 cases, 164 (5.0%) patients received hormone-replacement therapy (HRT); on the other hand, 253 (10.7%) of 2355 controls received HRT. The odds ratio was 0.432 (95% confidence intervals [CI], 0.352-0.53), and there was a significantly negative correlation between HRT use and breast cancer. The risk factors in Japanese women showed similar profiles to those in women in Western countries. However, we did find some different profiles of breast cancer risk in the Japanese women. Changing of lifestyle may increase breast cancer risk in Japan.

Entities:  

Mesh:

Year:  2008        PMID: 18307013     DOI: 10.1007/s10147-007-0728-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  16 in total

1.  Breast cancer and breastfeeding.

Authors:  François Eisinger; Wylie Burke
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

2.  Time-lag estimate between dietary intake and breast cancer mortality in Japan.

Authors:  Emiko Harashima; Yasue Nakagawa; Gunpei Urata; Keisuke Tsuji; Masuo Shirataka; Yasuhiro Matsumura
Journal:  Asia Pac J Clin Nutr       Date:  2007       Impact factor: 1.662

Review 3.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Authors: 
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

4.  Physical activity and the risk of breast cancer.

Authors:  I Thune; T Brenn; E Lund; M Gaard
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

5.  Premenopausal fat intake and risk of breast cancer.

Authors:  Eunyoung Cho; Donna Spiegelman; David J Hunter; Wendy Y Chen; Meir J Stampfer; Graham A Colditz; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

6.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

7.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.

Authors:  T J Key; P N Appleby; G K Reeves; A Roddam; J F Dorgan; C Longcope; F Z Stanczyk; H E Stephenson; R T Falk; R Miller; A Schatzkin; D S Allen; I S Fentiman; T J Key; D Y Wang; M Dowsett; H V Thomas; S E Hankinson; P Toniolo; A Akhmedkhanov; K Koenig; R E Shore; A Zeleniuch-Jacquotte; F Berrino; P Muti; A Micheli; V Krogh; S Sieri; V Pala; E Venturelli; G Secreto; E Barrett-Connor; G A Laughlin; M Kabuto; S Akiba; R G Stevens; K Neriishi; C E Land; J A Cauley; L H Kuller; S R Cummings; K J Helzlsouer; A J Alberg; T L Bush; G W Comstock; G B Gordon; S R Miller; C Longcope
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

8.  The decrease in breast-cancer incidence in 2003 in the United States.

Authors:  Peter M Ravdin; Kathleen A Cronin; Nadia Howlader; Christine D Berg; Rowan T Chlebowski; Eric J Feuer; Brenda K Edwards; Donald A Berry
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

9.  Exogenous estrogens and other factors in the epidemiology of breast cancer.

Authors:  J L Kelsey; D B Fischer; T R Holford; V A LiVoisi; E D Mostow; I S Goldenberg; C White
Journal:  J Natl Cancer Inst       Date:  1981-08       Impact factor: 13.506

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  7 in total

1.  Modifiable Risk of Breast Cancer in Northeast Iran: Hope for the Future. A Case-Control Study.

Authors:  Mohammad R Motie; Sima Besharat; Reza Torkjazi; Mahdieh Shojaa; Mahsa Besharat; Abbasali Keshtkar; Gholamreza Roshandel; Saba Besharat; Arab Ameri Fateme
Journal:  Breast Care (Basel)       Date:  2011-12-15       Impact factor: 2.860

2.  Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women.

Authors:  Wang-Hong Xu; Xiao-Ou Shu; Jirong Long; Wei Lu; Qiuyin Cai; Ying Zheng; Yong-Bing Xiang; Qi Dai; Gen-Ming Zhao; Kai Gu; Ping-Ping Bao; Yu-Tang Gao; Wei Zheng
Journal:  Am J Epidemiol       Date:  2011-03-07       Impact factor: 4.897

3.  Association between body mass index and incidence of breast cancer in premenopausal women: a Japanese nationwide database study.

Authors:  Takaaki Konishi; Michimasa Fujiogi; Nobuaki Michihata; Hiroki Matsui; Masahiko Tanabe; Yasuyuki Seto; Hideo Yasunaga
Journal:  Breast Cancer Res Treat       Date:  2022-06-04       Impact factor: 4.872

Review 4.  Breastfeeding and maternal health outcomes: a systematic review and meta-analysis.

Authors:  Ranadip Chowdhury; Bireshwar Sinha; Mari Jeeva Sankar; Sunita Taneja; Nita Bhandari; Nigel Rollins; Rajiv Bahl; Jose Martines
Journal:  Acta Paediatr       Date:  2015-12       Impact factor: 2.299

5.  Gail Model Underestimates Breast Cancer Risk in Thai Population.

Authors:  Doonyapat Sa-Nguanraksa; Thanyawat Sasanakietkul; Chayanuch O-Charoenrat; Anchalee Kulprom; Pornchai O-Charoenrat
Journal:  Asian Pac J Cancer Prev       Date:  2019-08-01

6.  Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States.

Authors:  Takeru Wakatsuki; Melissa J LaBonte; Pierre O Bohanes; Wu Zhang; Dongyun Yang; Mizutomo Azuma; Afsaneh Barzi; Yan Ning; Fotios Loupakis; Siamak Saadat; Nico Volz; Sebastian Stintzing; Rita El-Khoueiry; Wasaburo Koizumi; Masahiko Watanabe; Manish Shah; Justin Stebbing; Georgios Giamas; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2013-08-05       Impact factor: 6.261

7.  Screening breast magnetic resonance imaging in women with hormone replacement therapy.

Authors:  Feng Zhang; Qingjing Feng; Zhiyong Zhang; Yanjun Hu; Zhifeng Zhang
Journal:  Eur J Med Res       Date:  2018-10-20       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.